SCHEMBL22565333

SCHEMBL22565333

CC1(C)[C@H](C)C(C)(C)[C@H]1Oc1cnc(C#N)c(Br)c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24267520 0.84 KEAP1 (0.32) —
SCHEMBL24267412 0.82 AR (0.40) AR
SCHEMBL1846308 0.79 HPGDS (0.39) —
SCHEMBL22564873 0.76 AR (0.48) AR
SCHEMBL29919284 0.74 HPGDS (0.36) —
SCHEMBL22165375 0.74 CYP11B1 (0.40) —
SCHEMBL22565229 0.72 — —
SCHEMBL22565197 0.71 AR (0.31) AR
SCHEMBL22565200 0.71 NPC1 (0.35) —
SCHEMBL12806805 0.71 KDM4E (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3957633-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF Hinova Pharmaceuticals Inc. (CN) 2022-02-23 — — EP disclosed
WO-2020211822-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF 成都海创药业有限公司 2020-10-22 — — WO disclosed
Send feedback